APA

Taxel P., Dowsett R., Richter L., Fall P., Klepinger A. & Albertsen P. (20110104). Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer. : BJU international.

Chicago

Taxel Pamela, Dowsett Robert, Richter Lee, Fall Pamela, Klepinger Alison and Albertsen Peter. 20110104. Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer. : BJU international.

Harvard

Taxel P., Dowsett R., Richter L., Fall P., Klepinger A. and Albertsen P. (20110104). Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer. : BJU international.

MLA

Taxel Pamela, Dowsett Robert, Richter Lee, Fall Pamela, Klepinger Alison and Albertsen Peter. Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer. : BJU international. 20110104.